The correlation between dietary trans fatty acids and neoplasia was examined in the present study. Walker 256 tumor-bearing and control rats were fed a trans monounsaturated fatty acid (MUFA)-rich diet for 8 weeks and the incorporation of trans fatty acids by tumor tissue was examined. Also, the effect of tumor growth on trans fatty acid composition of plasma and liver, and the content of thiobarbituric acid-reactive substances (TBARS) was determined. Walker 256 tumor cells presented both trans and cis MUFAs given in the diet. The equivalent diet proportions were 0.66 for trans and 1.14 for cis. Taking into consideration the proportion of trans MUFAs in plasma (11.47%), the tumor incorporated these fatty acids in a more efficient manner (18.27%) than the liver (9.34%). Therefore, the dietary trans fatty acids present in the diet are actively incorporated by the tumor. Tumor growth itself caused marked changes in the proportion of polyunsaturated fatty acids in the plasma and liver but provoked only slight modifications in both trans and cis MUFAs. Tumor growth also reduced the unsaturation index in both plasma and liver, from 97.79 to 86.83 and from 77.51 to 69.64, respectively. This effect was partially related to an increase in the occurrence of the lipid oxidation/peroxidation process of TBARS content which was increased in both plasma (from 0.428 to 0.505) and liver (from 9.425 to 127.792) due to tumor growth.
Introduction
The fatty acids present in tissues are obtained either from dietary fat or by biosynthesis. All the biologically important saturated and monounsaturated fatty acids (MUFAs) can be fully synthesized from acetyl CoA in mammals. In contrast, omega-6 and omega-3 polyunsaturated fatty acids (PUFAs) cannot be completely synthesized (1) . All of these PUFAs are ultimately derived from the diet (2) . The dietary MUFAs, however, also modify the fatty acid composition of the tissues (3) .
The same principles apply to malignant cells, which derive all of their PUFAs from the circulation of the tumor-bearing host. The PUFAs are supplied either preformed or as precursors that are elongated and further desaturated by the cancer cells. Therefore, the type and amount of PUFAs available to a tumor depend on what is present in the circu-lation of the host, which, in turn, ultimately depends on the dietary fat intake. Because some of the phospholipid in tumor cells undergoes rapid turnover, certain membrane domains should respond quickly to changes in the fatty acid composition of the extracellular fluid. These observations suggest that it should be possible to change the fatty acid composition of a tumor by altering the dietary fat intake of the tumor-bearing host. Although we know that MUFAs can be synthesized by neoplastic tissue (4), it is not known if dietary MUFAs are actively incorporated by the tumor. However, if these changes occur they might alter the membrane functioning (5) and growth properties of the cancer cell or increase its sensitivity to cytotoxic agents (4) .
The effects of trans fatty acids from partially hydrogenated vegetable oils and other sources have been extensively examined (6, 7) . Investigations of diverse animal species and multigenerational experiments have revealed some adverse effects on the occurrence of various diseases (8) including cancer (9). In fact, several studies have shown that trans fatty acids present carcinogenic properties. In 1981, Awad (10) indicated that ingestion of elaidic acid (9t-18:1) reduced the survival time of mice bearing the Ehrlich ascites solid tumor. Hogan and Shamsuddin (11) compared the effects of a 25% elaidic acid diet and a 25% oleic acid diet on the development of colon tumors induced in rats by azoxymethane. The animals were kept on the diets for at least 20 weeks after the beginning of carcinogen exposure and the incidence of colon carcinoma was higher in the elaidic acid group, i.e., 37% against 23%. This issue, however, still remains in debate. Ip and Marshall (6) , in a review published in 1996, stated that there is no sufficient evidence to indicate that under properly controlled conditions the intake of trans fatty acids is a risk factor for cancer. The studies mentioned, however, did not determine many important aspects concerning the effects of trans fatty acids on neoplasias. For instance, the experiments lack the following determinations: 1) incorporation of trans fatty acids by the tumor tissue, 2) the effect of tumor growth on trans fatty acid composition of plasma and tissues, and 3) occurrence of lipid peroxidation in tumor-bearing rats fed a trans fatty acidrich diet. To address these points, Walker 256 tumor-bearing and control rats were fed a trans fatty acid-rich diet for 7 weeks. After this period the following parameters were examined: 1) fatty acid composition of the tumor, plasma and liver, and 2) the content of thiobarbituric acid-reactive substances (TBARS) in the same tissues and plasma.
The Walker 256 carcinosarcoma was discovered in 1928 as a spontaneous mammary tumor (12) . This tumor cell line has been used in many studies because it is easily transplanted and is species specific for rats (13) . This tumor grows rapidly, is quite invasive, and causes important metabolic and ionic changes in the host animal (14, 15) . The growth of this tumor leads to marked hormonal changes such as reduced insulinemia (16) , which has been assumed to result in the establishment of a cachexia state in two weeks (17) . Thus, this tumor model was chosen to investigate the above questions concerning trans fatty acids.
Material and Methods

Animals
Male Wistar rats (28 days old) weighing 45-50 g were obtained from the animal breeding unit, Faculty of Pharmaceutical Sciences, USP, São Paulo. Animals were maintained in a temperature-controlled room at 23 o C on a 12-h light-12-h dark cycle. During the 7-week experimental period, the rats were divided into two groups of 8 animals each, i.e., Walker 256 tumor-bearing rats and controls. The rats were fed a diet whose composition is shown in 
Tumor implantation
A Walker 256 cell suspension (approximately 3 x 10 4 cells in 1.0 ml) was subcutaneously injected into the left flank of the rats, and the controls were sham injected with 1.0 ml 0.9% NaCl solution (w/v) without anesthesia. The amount implanted ensured that the tumor mass was 8-10% of the carcass weight at the time of the experiments. All experiments were started between 8:00 and 10:00 h, 14-15 days after implantation.
Analysis of fatty acid composition
The total lipid fractions of the diets were analyzed for their fatty acid components using gas-liquid chromatography. Lipids were extracted from the diet and the tissues using the chloroform:methanol (2:1, v/v) mixture described by Folch et al. (18) . The samples were methylated by the method of Hartman and Lago (19) . After removing the solvent under a stream of N 2 , fatty acid methyl esters were resuspended in chloroform and analyzed with a CG-500 gas chromatograph equipped with a flame ionization detector linked to a CG-30021 integrator-processor (CG Instrumentos Científicos Ltda., São Paulo, SP, Brazil). The gas liquid chromatography column was a SP-2560, 100 m x 0.25 mm ID, 20-µm film thickness (Supelco Park, Bellefonte, PA, USA). The column temperature was programmed from 125 o to 175 o C at a rate of 1 o C/ min and held at 175 o C for 25 min. The detector and the injector temperatures were 235 o and 225 o C, respectively. The retention times of the fatty acid methyl ester peaks were compared with those of known standards, and the relative levels of individual fatty acids were calculated as a percentage of the total fatty acids. The fatty acids containing more than 18 carbons and 3 double bonds were less than 10% and were not considered for the calculations. In fact, this study was focused on incorporation of the fatty acids given in the diet, mainly the trans fatty acids.
Unsaturation index
The unsaturation index of the fatty acids present in the tissues and plasma was calculated. The percentage of each fatty acid was multiplied by the number of double bonds present in the molecule (5). 
TBARS determination
The extraction medium used for the measurement of TBARS content in tissues and plasma contained 0.10 M sodium phosphate, pH 7.0 (20) . TBARS were measured as previously described by Winterbourn et al. (21) . The spectrophotometric measurements were carried out at 25 o C and the results expressed as µmol per mg tissue protein.
Protein determination
Protein content was assessed by the method of Lowry et al. (22) , using BSA (Sigma) as standard.
Statistical analysis
Results are reported as means ± SD for 8 rats. The paired Student t-test was employed to compare the effect of tumor growth, and the level of significance was set at P<0.05. The GraphPad Instat software, version 2.01, was used for statistical analysis.
Results
The proportion of saturated fatty acids in tumor tissue was similar to that present in the diet, i.e., 28% (Tables 1 and 2 ). The proportion of trans MUFAs was 9.23% lower, whereas that of cis MUFAs and cis PUFAs was 5.49 and 3.09% higher, respectively, as compared to the diet. However, the unsaturation index was quite similar.
The Walker 256 tumor growth did not markedly alter the proportion of saturated and trans MUFAs in plasma (Table 3) . However, the presence of the tumor raised the percentage of cis MUFAs (mainly C18:1 9c + 13t + 14t) by 6.05% and the percentage of cis PUFAs by 3.69%. The trans PUFA (C18:2 9c, 12t) was not detected in plasma of tumorbearing rats. The unsaturation index of the plasma fatty acids was decreased due to the presence of the tumor (10.96%).
Tumor growth decreased the proportion of C18:0 in the liver, whereas C14:0 was found in the tumor group only, leading to a 6.83% increase in the proportion of total saturated fatty acids in the latter group (Table  4 ). The proportion of total trans MUFAs in the liver was not modified by the presence of the tumor. However, C18:1 6-8t decreased, C18:1 9t and C18:1 12t appeared, and C18:1 11t decreased due to neoplasia. The proportion of all cis MUFAs was reduced by tumor growth in the liver. Trans PUFAs were enhanced in the liver of tumor-bearing rats due to the detection of C18:2 tc, C18:2 9t, 12t and C18:2 9t, 12c. C18:2 9c, 12c was decreased but C18:3 9c, 12c, 15t and C18:3 9c, 12c, 15c appeared in the hepatic tissue of the tumor group, so that the total proportion of cis PUFAs was unchanged.
TBARS content in the tumor was 5-fold higher than in the liver of the control group. Tumor growth raised the TBARS content in plasma by 18% and caused a remarkable 14-fold increment of these compounds in the liver (Table 5 ).
Discussion
Several studies have shown that the fatty acid composition of tissues is changed by altering the dietary fat (5), particularly PUFAs. Tumor cells can synthesize MUFAs and so the incorporation of these fatty acids given in the diet by the tumor was an important aspect to be examined. The first question addressed in this study was: are the trans and cis MUFAs similarly incorporated by the tumor?
The Walker 256 tumor cells incorporated both trans and cis MUFAs given in the diet. The equivalent diet proportions were 0.66 for trans and 1.14 for cis. Clearly, the proportion of trans MUFAs was much lower in the tumor compared to the proportion in the diet. In fact, the cis MUFAs/trans MUFAs ratio was 1.34 in the diet and 2.31 in the tumor. These findings permit us to assume that trans MUFAs may not be actively incorporated by Walker 256 tumor tissue. However, the dietary fatty acids have to be digested and absorbed as chylomicrons before being incorporated by the tissues, showing that the cells can only incorporate the lipids in the surroundings. As compared with the proportion of trans MUFAs in the diet (27.5%), the percentage of these fatty acids was low in plasma (11.47%) and still lower in the liver (9.34%), equivalent to dietary proportions of 0.42 and 0.33, respectively. Thus, the proportion of trans MUFAs in the tumor (18.27%) was about 9% higher than the values found in plasma and liver. Therefore, taking into consideration the proportion of these fatty acids in plasma, the tumor incorporated trans MUFAs in a more efficient manner than the liver. On the other hand, the equivalent plasma proportion was 1.32 and 1.12 for trans and cis MUFAs, respectively, in the tumor-bearing rats. These findings support the proposition that trans MUFAs may be more actively incorporated by the tumor than cis MUFAs. Experiments in cultured cells are now required to further examine this matter (23). Our observations, however, suggest that it should be possible to change the MUFA composition of a tumor by altering the type of dietary fat ingested by the tumor-bearing host. Membrane functioning and production of vital lipid mediators may be altered, possibly leading to changes in the growth properties of the cancer tissue (24) . As a result, this may also raise the sensitivity of the neoplastic cells to cytotoxic agents.
The second question addressed was: what is the effect of tumor growth on trans MUFA composition in tissues and plasma? Walker 256 tumor grows very rapidly, stimulates catabolic pathways and leads to cachexia in about two weeks (25, 26) . Among the metabolic pathways, lipolysis is markedly activated, possibly causing important changes in the proportion of fatty acids in tissues. Tumor growth caused only slight changes in the proportion of trans and cis MUFAs in plasma, a cis/trans ratio of 2.76 in the control and 2.71 in the tumor-bearing groups. Nevertheless, the proportion of trans PUFAs was markedly reduced. In fact, the cis PUFA/ trans PUFA ratio was 0.84 in the control and 14.35 in the tumor-bearing groups. In the liver, a similar observation was made for MUFAs. The cis MUFAs/trans MUFAs ratio was 2.9 in controls and 2.5 in tumorbearing rats. However, the proportion of cis PUFAs to trans PUFAs was markedly decreased due to tumor growth, i.e., 12.39 compared to 35.93. These findings support the proposition that tumor growth causes important changes in the proportion of PUFAs but provokes only slight modifications in both trans and cis MUFAs. The preferential effect of tumor growth on PUFAs is an interesting finding which remains to be elucidated. One possible explanation for this observation may be related to the acylation/ deacylation process (27) , which might be activated under these conditions.
It is noteworthy that tumor growth reduced the unsaturation index in both plasma and liver. This decrease in the abundance of double bonds could be the result of an increased occurrence of lipid oxidation/peroxidation. The oxidation/peroxidation process of double bonds facilitates the removal of unsaturated fatty acids from the phospholipid moieties (28) , thus reducing the proportion of these types of fatty acids in the cells. Therefore, the third point addressed was the measurement of TBARS content in plasma and tissues. It has been postulated that the lipid peroxidation/oxidation process plays a key role in tumor growth and invasiveness (29) . This may explain the high content of TBARS in the tumor as compared to liver and plasma of the control group. In addition, however, tumor growth slightly increased TBARS content in plasma but greatly increased this compound in the liver. Therefore, tumor growth, by leading to hormonal, metabolic and ionic changes in the host, may favor the occurrence of lipid oxidation/peroxidation in non-tumor tissues and plasma. However, the tumor itself may release products of lipid oxidation/peroxidation that are exported to the liver. The results presented here led us to postulate that trans fatty acids present in the diet are actively incorporated by the tumor. This fact can be used as a dietary strategy during cancer treatment if trans fatty acids somehow affect the rate of tumor growth. This is an important issue to be investigated. The tumor growth itself also alters the proportion of fatty acids in tissues and plasma and this may partially result from an increased occurrence of lipid oxidation/peroxidation.
